Complete Filing Data
Omada Health, Inc. reported Temporary Equity Shares Outstanding of 0 shares for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Omada Health, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income Loss | -$12.8M | -$47.1M | -$67.5M |
| Comprehensive Income Net Of Tax | -$12.8M | -$47.1M | -$67.5M |
| Selling And Marketing Expense | $90.0M | $68.1M | $66.2M |
| Revenue From Contract With Customer Excluding Assessed Tax | $260.2M | $169.8M | $122.8M |
| Research And Development Expense | $40.7M | $35.9M | $33.7M |
| Operating Income Loss | -$12.0M | -$43.7M | -$66.0M |
| Operating Expenses | $182.9M | $146.5M | $136.0M |
| Nonoperating Income Expense | -$806.0K | -$3.5M | -$1.5M |
| Interest Expense Nonoperating | $2.5M | $4.5M | $4.7M |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$12.8M | -$47.1M | -$67.5M |
| Gross Profit | $170.9M | $102.9M | $70.0M |
| General And Administrative Expense | $52.2M | $42.6M | $36.0M |
| Cost Of Revenue | $89.3M | $66.9M | $52.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$3.2M | -$5.3M | -$9.4M | -$9.2M | -$10.7M | -$19.0M |
| Comprehensive Income Net Of Tax | -$3.2M | -$5.3M | -$9.4M | -$9.2M | -$10.7M | -$19.0M |
| Selling And Marketing Expense | $22.9M | $22.3M | $17.6M | $15.2M | ||
| Revenue From Contract With Customer Excluding Assessed Tax | $68.0M | $61.4M | $45.5M | $41.2M | ||
| Research And Development Expense | $10.3M | $10.0M | $8.9M | $9.0M | ||
| Operating Income Loss | -$2.5M | -$4.3M | -$8.5M | -$10.0M | ||
| Operating Expenses | $47.6M | $44.7M | $37.1M | $34.9M | ||
| Nonoperating Income Expense | -$665.0K | -$967.0K | -$702.0K | -$655.0K | ||
| Interest Expense Nonoperating | $353.0K | $1.1M | $1.1M | $1.1M | ||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.2M | -$5.3M | -$9.2M | -$10.7M | ||
| Gross Profit | $45.1M | $40.3M | $28.6M | $24.8M | ||
| General And Administrative Expense | $14.3M | $12.3M | $10.7M | $10.7M | ||
| Cost Of Revenue | $23.0M | $21.1M | $17.0M | $16.4M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $449.0M | $449.0M | $448.8M |
| Stockholders Equity | $229.7M | -$384.4M | -$350.1M | -$293.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $222.0M | $76.4M | $115.6M | $168.1M |
| Operating Lease Right Of Use Asset Amortization Expense | $447.0K | $728.0K | $683.0K | |
| Gains Losses On Extinguishment Of Debt | -$2.1M | $0.00 | -$1.5M | |
| Gain Loss On Sale Of Property Plant Equipment | -$8.0K | -$2.0K | -$151.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $145.6M | -$39.3M | -$52.5M | |
| Amortization Of Deferred Sales Commissions | $3.3M | $2.6M | $1.8M | |
| Temporary Equity Value Excluding Additional Paid In Capital | $0.00 | $0.00 | ||
| Retained Earnings Accumulated Deficit | -$456.7M | -$444.0M | ||
| Property Plant And Equipment Net | $7.9M | $5.6M | ||
| Prepaid Expense And Other Assets Current | $8.3M | $6.9M | ||
| Other Liabilities Noncurrent | $0.00 | $285.0K | ||
| Other Assets Noncurrent | $165.0K | $5.0M | ||
| Operating Lease Right Of Use Asset | $0.00 | $447.0K | ||
| Operating Lease Liability Current | $0.00 | $415.0K | ||
| Long Term Debt | $0.00 | $29.8M | ||
| Liabilities Current | $75.7M | $54.0M | ||
| Liabilities And Stockholders Equity | $305.4M | $150.9M | ||
| Liabilities | $75.7M | $86.3M | ||
| Inventory Net | $4.5M | $3.3M | ||
| Intangible Assets Net Excluding Goodwill | $2.4M | $4.3M | ||
| Goodwill | $13.2M | $13.2M | ||
| Contract With Customer Liability Current | $25.1M | $19.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $449.0M | $449.0M | $449.0M | $449.0M |
| Stockholders Equity | $217.3M | $214.2M | -$390.0M | -$379.8M | -$373.4M | -$365.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $198.6M | $223.1M | $83.7M | $84.2M | ||
| Operating Lease Right Of Use Asset Amortization Expense | ||||||
| Gains Losses On Extinguishment Of Debt | -$2.1M | $0.00 | ||||
| Gain Loss On Sale Of Property Plant Equipment | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | ||||||
| Amortization Of Deferred Sales Commissions | ||||||
| Temporary Equity Value Excluding Additional Paid In Capital | $0.00 | $0.00 | ||||
| Retained Earnings Accumulated Deficit | -$461.9M | -$458.7M | ||||
| Property Plant And Equipment Net | $7.5M | $6.5M | ||||
| Prepaid Expense And Other Assets Current | $8.4M | $7.8M | ||||
| Other Liabilities Noncurrent | $0.00 | $373.0K | ||||
| Other Assets Noncurrent | $199.0K | $234.0K | ||||
| Operating Lease Right Of Use Asset | $0.00 | $65.0K | ||||
| Operating Lease Liability Current | $0.00 | $0.00 | ||||
| Long Term Debt | $0.00 | $30.0M | ||||
| Liabilities Current | $70.1M | $58.0M | ||||
| Liabilities And Stockholders Equity | $287.5M | $303.0M | ||||
| Liabilities | $70.1M | $88.8M | ||||
| Inventory Net | $3.1M | $3.5M | ||||
| Intangible Assets Net Excluding Goodwill | $2.9M | $3.3M | ||||
| Goodwill | $13.2M | $13.2M | ||||
| Contract With Customer Liability Current | $27.2M | $25.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Proceeds From Issuance Initial Public Offering | $160.5M | $0.00 | $0.00 |
| Share Based Compensation Capitalized Software Development Costs | $184.0K | $97.0K | $76.0K |
| Share Based Compensation | $13.0M | $9.4M | $8.7M |
| Proceeds From Stock Options Exercised | $9.4M | $3.3M | $1.8M |
| Payments To Develop Software | $4.5M | $3.3M | $2.5M |
| Payments To Acquire Property Plant And Equipment | $1.3M | $596.0K | $416.0K |
| Payments Of Stock Issuance Costs | $4.3M | $4.5M | $111.0K |
| Net Cash Provided By Used In Operating Activities | $18.3M | -$34.2M | -$49.7M |
| Net Cash Provided By Used In Investing Activities | -$5.8M | -$3.9M | -$2.9M |
| Net Cash Provided By Used In Financing Activities | $133.2M | -$1.2M | $179.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.4M | $1.9M | $1.5M |
| Increase Decrease In Other Noncurrent Liabilities | $0.00 | $180.0K | $105.0K |
| Increase Decrease In Other Noncurrent Assets | -$251.0K | -$409.0K | -$213.0K |
| Increase Decrease In Operating Lease Liability | -$415.0K | -$783.0K | -$716.0K |
| Increase Decrease In Inventories | $1.2M | -$318.0K | $74.0K |
| Increase Decrease In Contract With Customer Liability | $5.5M | $4.6M | $1.4M |
| Increase Decrease In Contract With Customer Asset | $3.5M | $6.4M | $3.7M |
| Increase Decrease In Accrued Liabilities | $10.6M | $5.3M | $8.3M |
| Increase Decrease In Accounts Receivable | $12.4M | $8.8M | $5.3M |
| Increase Decrease In Accounts Payable | $6.3M | $399.0K | -$286.0K |
| Depreciation Depletion And Amortization | $5.5M | $4.8M | $4.4M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Temporary Equity Shares Outstanding | 0.00 | 118.2M | 118.2M | 118.1M |
| Weighted Average Number Of Shares Outstanding Basic | 36.6M | 7.7M | 7.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 36.6M | 7.7M | 7.1M | |
| Earnings Per Share Diluted | $-0.35 | $-6.11 | $-9.52 | |
| Earnings Per Share Basic | $-0.35 | $-6.11 | $-9.52 | |
| Common Stock Shares Authorized | 750.0M | 181.5M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | ||
| Temporary Equity Shares Issued | 0.00 | 118.2M | ||
| Temporary Equity Shares Authorized | 0.00 | 120.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 118.2M | 118.2M | 118.2M | 118.2M |
| Weighted Average Number Of Shares Outstanding Basic | 57.7M | 22.0M | 7.8M | 7.6M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 57.7M | 22.0M | 7.8M | 7.6M | ||
| Earnings Per Share Diluted | $-0.06 | $-0.24 | $-1.18 | $-1.40 | ||
| Earnings Per Share Basic | $-0.06 | $-0.24 | $-1.18 | $-1.40 | ||
| Common Stock Shares Authorized | 750.0M | 750.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | ||||
| Temporary Equity Shares Issued | 0.00 | 0.00 | ||||
| Temporary Equity Shares Authorized | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $9.7M | $3.3M | $1.8M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $13.1M | $9.5M | $8.8M |
| Provision For Doubtful Accounts | $1.2M | $1.8M | $452.0K |
| Investment Income Interest | $5.3M | $805.0K | $5.8M |
| Fair Value Adjustment Of Warrants | $1.5M | -$218.0K | $1.0M |
| Stock Issuance Costs Incurred But Not Yet Paid | $0.00 | $131.0K | $23.0K |
| Interest Paid Net | $2.4M | $3.9M | $4.1M |
| Conversion Of Stock Amount Converted1 | $452.1M | $0.00 | $0.00 |
| Capital Expenditures Incurred But Not Yet Paid | $16.0K | $65.0K | $26.0K |
| Amortization Of Financing Costs | $285.0K | $389.0K | $416.0K |
| Warrants And Rights Outstanding | $0.00 | $2.3M | |
| Contract With Customer Asset Net Noncurrent | $8.7M | $9.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $2.3M | $3.0M | $919.0K | $666.0K | $391.0K | $988.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.6M | $2.9M | $2.9M | $2.2M | $2.1M | $2.9M |
| Provision For Doubtful Accounts | $995.0K | $141.0K | $262.0K | -$327.0K | ||
| Investment Income Interest | $2.0M | $863.0K | $17.0K | $85.0K | ||
| Fair Value Adjustment Of Warrants | $212.0K | $736.0K | -$428.0K | -$392.0K | ||
| Stock Issuance Costs Incurred But Not Yet Paid | ||||||
| Interest Paid Net | ||||||
| Conversion Of Stock Amount Converted1 | ||||||
| Capital Expenditures Incurred But Not Yet Paid | ||||||
| Amortization Of Financing Costs | ||||||
| Warrants And Rights Outstanding | $0.00 | $430.0K | ||||
| Contract With Customer Asset Net Noncurrent | $8.7M | $8.6M |
Most recent annual filing with the SEC: March 6, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.